A state-of-the-art, multipod facility for studies of infectious human pathogens
Located at the Glen site of the Research Institute of the McGill University Health Centre (RI‑MUHC), the Containment Level 3 (CL3) Platform is one of the exceptional Centre for Translational Biology (CTB) Technology Platforms, offering services and equipment for biomedical research.
Applications and services
The CL3 Platform offers highly controlled biosafety laboratories where live pathogenic bacteria and viruses can be studied in three independent research pods. With a joint allocation of 545 square metres, each pod meets the highest safety standards defined by Canadian Biosafety Standards and Guidelines (PHAC and CFIA). Certification for work with SARS CoV-2 was received in 2020.
The CL3 facility manager oversees essential training, provides guidance to researchers, monitors experiments and ensures strict adherence to standard operating procedures (SOPs).
The CL3 Platform is available to RI-MUHC researchers, affiliated collaborators and external researchers with approved protocols on a fee-for-service basis.
The platform studies:
- Human immunodeficiency virus (HIV)
Access our services
Contact the CL3 Platform to discuss your research needs. We welcome your inquiries!
Fiona McIntosh, B.Sc.
Platform Manager514-934-1934, ext. 44619
Andréanne Lupien, PhD
Centre for Translational Biology Technology Platforms
The CTB Technology Platforms provide access to state-of-the-art technologies and instrumentation as well as top-level scientific expertise and training. Watch the video, explore the links below, and prepare to accelerate your research!